從冠脂妥偽藥事件談藥師之專業責任與歸責問題【本期企劃】 試閱
Analysis for Responsibility of Pharmacists to Dispense Counterfeit Drug of Crestor
藥品由製造、運送到調劑供應病人使用,依法皆設有藥事人員為用藥安全及品質把關。冠脂妥之偽藥事件即係由藥師於調劑時發現,經主管機關確認為偽藥,各流程均設有藥事法相關條文之適用。本文探討藥品安全與藥師專業責任,以及不法藥品之管理法制,並以冠脂妥之偽藥事件,分析藥師調劑供應偽藥之歸責問題。
The medicines are used from the manufacture, delivery and dispensing to the patients. According to the law, the pharmacy personnel are responsible for the safety and quality of the medication. The counterfeit-drug incident of Crestor was discovered by the pharmacist when it was dispending, and the relevant provisions of the Pharmaceutical Affairs Act were applicable to each process. This article explores the drug safety and the professional responsibility of pharmacists and the legal system of illegal drugs, in the case of counterfeit drug of Crestor, analyzes the blame for the supply of counterfeit drugs by pharmacists.
031-043